Abstract

Phthalates are a class of endocrine disrupting chemicals with near ubiquitous exposure to populations around the world. Phthalates have been associated with children's adiposity in previous studies, though discrepancies exist across studies that may be due to timing of exposure or outcome assessment and population differences (i.e., genetics, other confounders). DNA methylation, an epigenetic modification involved in gene regulation, may mediate the effects of early life phthalate exposures on health outcomes. This study aims to evaluate the mediating effect of DNA methylation at growth-related genes on the association between phthalate exposure and repeat measures of adiposity (BMI-for-age z-score, waist circumference, and skinfolds thickness) in Mexican children. Urinary phthalate metabolite concentrations were quantified in mothers at each of the three trimesters of pregnancy and in children at the first peri-adolescent study visit. Blood leukocyte DNA methylation at H19 and HSD11B2 was quantified during the first peri-adolescent visit, and adiposity was measured at the first visit and again ~3 years later among participants (n = 109 boys, 114 girls) from the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) project. Associations between phthalates or DNA methylation and repeat outcome measures were assessed separately in boys and girls using generalized estimating equation models including covariates (urinary specific gravity, maternal education, and child's age). Sobel tests were used to assess DNA methylation as a mediator in models adjusting for the same covariates. Associations between phthalates and adiposity varied by phthalate and timing of exposure. Early gestation MBP, MIBP, and MBzP were associated with adiposity among girls. For example, among girls first trimester maternal urine concentrations of MIBP were associated with increases in skinfold thickness, BMI-for-age, and waist circumference (p < 0.01). Second trimester and adolescent MBzP were associated with adiposity among boys in opposite directions. In girls, H19 methylation was positively associated with skinfold thickness. No significant mediation of phthalate exposure on adiposity by DNA methylation of H19 or HSD11B2 was observed (Sobel p > 0.05). However, the mediation analysis was underpowered to detect small to medium effect sizes, and the role of DNA methylation as a mediator between phthalates and outcomes merits further study.

Highlights

  • Endocrine disrupting chemicals (EDCs) represent a class of ubiquitous exposures to humans that disrupt the body’s natural hormonal functions and subsequent reproductive and developmental health

  • This study aims to extend the evaluation of phthalate exposures and peri-adolescent adiposity to include trimesterspecific measures across pregnancy and repeat measures of adiposity in ELEMENT children

  • Our results show that phthalate exposures during pregnancy and in early adolescence have sex-specific associations with DNA methylation and sex- and exposure timing-specific associations with repeat measures of adolescent adiposity

Read more

Summary

Introduction

Endocrine disrupting chemicals (EDCs) represent a class of ubiquitous exposures to humans that disrupt the body’s natural hormonal functions and subsequent reproductive and developmental health. Phthalate metabolites were detected at rates of 79.1–99.3% in a study of U.S children from California [2] and 95.6–100% among pregnant women from Mexico City [3]. Pregnant women and developing children are susceptible to the endocrine disrupting effects of phthalates and other EDCs [1]. Previous studies have shown that phthalate exposures, both in utero and during adolescence, are associated with measures of weight status and adiposity, with effects varying by phthalate metabolite, timing of exposure and outcome assessment, and sex [6, 8,9,10,11,12]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.